L01CD02 |
B |
Docetaxel (trihydrated) - 80mg/4ml |
1779 |
208379/97 |
TAXOTERE |
80mg/4ml |
1 x 2ml + 6ml |
Injectable concentrated solution+diluent |
Infusion |
Mersaco |
Sanofi Aventis Deutschland GmbH |
Germany |
24,150,868 L.L |
19.35 |
D |
Aventis Pharma SA |
France |
03/04/20 |
|
L01CD02 |
B |
Docetaxel (trihydrated) - 80mg/4ml |
11069 |
81922/1 |
TAXOTERE |
80mg/4ml |
1 x 2ml + 6ml |
Injectable concentrated solution+diluent |
Infusion |
Mersaco |
Sanofi Aventis Deutschland GmbH |
Germany |
24,150,868 L.L |
19.35 |
D |
Sanofi Mature IP |
France |
03/04/20 |
|
L01CD02 |
G |
Docetaxel - 40mg/ml |
1731 |
148395/04 |
DOCETAXEL GP PHARM |
80mg/2ml |
1 x 2ml + 6ml |
Injectable concentrated solution+diluent |
Infusion |
Mediterranean Pharmaceutical Company |
GP-Pharm, SA |
Argentine |
16,777,239 L.L |
19.35 |
D |
|
|
03/04/20 |
|
L01CD02 |
G |
Docetaxel - 80mg/4ml |
8735 |
56916/1 |
DOCETAXEL ACCORD |
80mg/4ml |
1 |
Injectable concentrate for solution |
Infusion |
Mediterranean Pharmaceutical Company |
Accord Healthcare Limited |
UK |
15,099,641 L.L |
19.35 |
D |
Accord Healthcare Limited |
UK |
03/04/20 |
|
L01CD02 |
G |
Docetaxel - 80mg/4ml |
11268 |
7821/1 |
DOCETAXEL SPC |
80mg/4ml |
1x4ml |
Injectable concentrate for solution |
Infusion |
Advanced Healthcare Services SAL |
Pharmaline SAL Licensed by Sudair Pharma Company, KSA |
Lebanon |
16,906,027 L.L |
19.35 |
D |
|
|
03/04/20 |
|